Overview

A class action lawsuit has been filed against Helen of Troy Limited (“Helen of Troy” or the “Company”) (NASDAQ : HELE) and certain of the Company’s senior officers (collectively, “Defendants”), alleging violations of the federal securities laws. The Helen of Troy lawsuit is brought on behalf of all persons and entities who purchased or otherwise acquired Helen of Troy common stock between April 24, 2024, and October 8, 2025, inclusive (the “Class Period”). Investors have until June 2, 2026, to seek appointment as lead plaintiff of the Helen of Troy class action lawsuit.

Helen of Troy markets consumer goods across outdoor, beauty, and wellness segments. Before the Class Period, the Company pursued an aggressive growth-by-acquisition strategy. As integration challenges, rising costs, and slowing organic growth created investor concern, Helen of Troy launched Project Pegasus, a restructuring program designed to improve operating margins, reduce inventory, improve cash flow, and generate savings for reinvestment in the Company’s brands and business.

The complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding Project Pegasus and Helen of Troy’s business prospects. Defendants allegedly touted Project Pegasus as generating “fuel” for growth, claimed the initiative was progressing successfully, and reassured investors that the Company remained on track to deliver meaningful savings and efficiencies.

In reality, according to the complaint, Project Pegasus was not delivering the efficiencies Defendants represented. The complaint alleges that Helen of Troy lacked sufficient budget and resources to achieve its stated restructuring and cost-savings goals, and that Defendants concealed these adverse facts while continuing to tout Project Pegasus and the Company’s operational progress.

The truth began to emerge on July 9, 2024, when Helen of Troy reported first-quarter fiscal 2025 results, including a 49% year-over-year decline in earnings per share, and reduced its full-year revenue outlook by more than 20%. On this news, Helen of Troy’s stock price declined $24.68 per share, or 27.7%.

Additional disclosures followed. On May 2, 2025, Helen of Troy announced the sudden departure of Noel Geoffroy, who had spearheaded Project Pegasus and had served as CEO for only 14 months. Then, on July 10, 2025, the Company reported that first-quarter fiscal 2026 net sales had declined 11% year-over-year, adjusted earnings per share had declined nearly 60%, and the Company had recorded a $414.4 million goodwill impairment. On this news, Helen of Troy’s stock price declined $7.04 per share, or 22.7%.

Then, on October 9, 2025, Helen of Troy reported second-quarter fiscal 2026 results, including an 8.9% year-over-year decline in quarterly sales and a 51% decline in adjusted earnings per share. The Company also disclosed significant business disruptions and cost headwinds that it expected to continue for the remainder of the year. Following these disclosures, Helen of Troy’s stock price declined $6.90 per share, or 25%.

*          *          *

If you purchased or otherwise acquired Helen of Troy common stock between April 24, 2024, and October 8, 2025, and you wish to serve as lead plaintiff in this lawsuit, you are encouraged to submit your information to DiCello Levitt LLP via the form on this page. 

You can also contact DiCello Levitt attorneys Brian O’Mara and Hani Farah by calling (888) 287-9005 or at investors@dicellolevitt.com. 

The deadline to apply to the Court to serve as a lead plaintiff in the Helen of Troy class action lawsuit is August 3, 2026.